Galapagos | GLPG - Ebit

Stock Price
29.24
Daily Change
0.08 0.27%
Monthly
7.11%
Yearly
33.76%
Q1 Forecast
27.75

Galapagos reported EUR-41.67M in EBIT for its fiscal quarter ending in September of 2025.





Ebit Change Date
argenx SE USD 349.97M 61.94M Sep/2025
AstraZeneca USD -1.5B 5.01B Sep/2025
Biogen USD 659.6M 157M Sep/2025
Genmab DKK 432M 900.27M Jun/2025
Gilead Sciences USD 3.51B 810M Sep/2025
GlaxoSmithKline GBP 2.79B 716M Sep/2025
GRIFOLS EUR 352.11M 20.18M Sep/2025
Hikma Pharmaceutical USD 317M 85M Dec/2024
Incyte USD 431.31M 120.49M Sep/2025
Merck EUR 1.21B 180M Sep/2025
Neurocrine Biosciences USD 239.3M 93.7M Sep/2025
Novartis USD -9.19B 13.87B Jun/2025
Roche Holding CHF 9.56B 2.1B Dec/2025
Sanofi EUR 1.7B 2.17B Dec/2025
UCB EUR 502M 168M Dec/2024
Vertex Pharmaceuticals USD 1.24B 84.6M Sep/2025